Ticker Symbol: PTIX
Protagenic Therapeutics Inc
$1.94 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001022899
Company Profile
Protagenic Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics offers its services in the United States.
Sector: Administrative and Support and Waste Management and Remediation Services
Industry: All Other Business Support Services
Standard Industrial Classification Code (SIC code): 7389
Address: N/A
Website: protagenic.com
CEO: N/A
Tags:
- Internet Software/Services
- Technology Services
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.72
Change:
-$0.07
(
-3.91%)
Days Range: $1.61 - $1.80
Beta: -
52wk. High: $2.74
52wk. Low: $0.72
Ytd. Change 7.96%
50 Day Moving Average: $1.49
200 Day Moving Average: $1.83
Shares Outstanding: 4330959
Valuation
Market Cap: 744.9M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A